Koenraad Dierick is the Vice President Patient Access at Terumo Blood and Cell Technologies. He leads a global team of government affairs, medical affairs and market access experts focused on interacting across the healthcare environment to remove barriers that prevent patients from accessing the care they need. Using evidence generation, medical education, awareness building and health economics his team is responsible for ensuring the company’s technologies directly improve the health outcomes of patients through appropriate funding and evaluation in target global geographies, ultimately resulting in more patients gaining access to treatments. Koenraad has over 20 years of experience in business development, market access, government affairs, medical education and market research across different industries including medical devices, pharma, life sciences, cell therapy, OTC, and fast-moving consumer goods.
At a moment when medication therapy for sickle cell disease (SCD) leaves too many behind and widespread access to curative gene therapies still lies in the distant future, automated red blood cell exchange is experiencing renewed interest. To improve patients’ lives, a broad commitment is needed to expand access to transfusion therapies.